Related Experiment Video
Updated: Aug 9, 2026
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma
A Mohan1, M Kandalam, H L Ramkumar
1Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai - 600 006, Tamil Nadu, India.
The British Journal of Ophthalmology
|March 25, 2006
Summary
Cancer stem cell marker ABCG2 and neural stem cell marker MCM2 are more expressed in invasive retinoblastoma tumors. This suggests a potential role for these markers in predicting tumor invasiveness and metastasis.
Area of Science:
- Ophthalmology
- Oncology
- Stem Cell Biology
Background:
- Retinoblastoma is a pediatric eye cancer.
- Cancer stem cell (CSC) markers are implicated in tumor progression and metastasis.
- Neural stem cell markers may also play a role in certain cancers.
Purpose of the Study:
- To investigate the expression of ABCG2 and MCM2 in retinoblastoma.
- To correlate the expression of these markers with clinicopathological features, including tumor invasion and treatment response.
Main Methods:
- Immunohistochemistry was used to assess ABCG2 and MCM2 expression in 39 retinoblastoma samples.
- Tumor samples were categorized based on chemotherapy history and invasion status (choroid/optic nerve).
Main Results:
- ABCG2 and MCM2 expression was significantly higher in invasive retinoblastoma tumors (p < 0.01).
- Both markers were frequently expressed in tumors that recurred or metastasized.
- Non-neoplastic retina also showed positive expression for ABCG2 and MCM2.
Conclusions:
- ABCG2 and MCM2 expression is associated with increased tumor invasiveness in retinoblastoma.
- These markers may serve as potential indicators of aggressive disease.
- Further research is warranted to elucidate the precise role of ABCG2 and MCM2 in retinoblastoma pathogenesis.
